120 results
8-K
EX-99.1
CORT
Corcept Therapeutics Inc
1 May 24
Corcept Therapeutics Announces First Quarter Financial Results
4:09pm
– enrollment continues
“Fully enrolling ROSELLA takes us a big step closer to addressing the unmet medical need of women with platinum-resistant
8-K
EX-99.1
CORT
Corcept Therapeutics Inc
15 Feb 24
Corcept Therapeutics Announces Fourth Quarter Financial Results
4:11pm
), it will constitute a major medical advance and could establish the combination of relacorilant and nab-paclitaxel as a new standard of care for women
8-K
EX-99.1
b4t14w4 l9b
3 Nov 22
Corcept Therapeutics Announces Third Quarter Financial Results
4:09pm
8-K
EX-99.1
325gsk 9u
3 Aug 22
Corcept Therapeutics Announces Second Quarter Financial Results
4:15pm
8-K
EX-99.1
fx54mskf
5 May 22
Corcept Therapeutics Announces First Quarter Financial Results
12:00am
8-K
EX-99.1
fmx0vwoel39
29 Jul 21
Corcept Therapeutics Announces Second Quarter Financial Results
4:14pm